Aditxt (ADTX) Free Cash Flow (2019 - 2026)
Aditxt (ADTX) recorded quarterly Free Cash Flow of -$4.6 million in Q1 2026, up 50.36% quarter-over-quarter from -$9.2 million in Q4 2025, and up 60.82% on a YoY basis from -$2.9 million in Q1 2025.
Aditxt (ADTX) Free Cash Flow (2019 - 2026) Analysis & Trends
Aditxt's Free Cash Flow history runs 8 years deep, the most recent figure standing at -$4.6 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 60.82% year-over-year to -$4.6 million; the TTM figure through Mar 2026 stood at -$18.6 million (up 17.55% YoY), while the FY2025 annual figure was -$25.7 million, down 53.33% from the prior year.
- Free Cash Flow was -$4.6 million for Q1 2026 at Aditxt, up from -$9.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$2.3 million in Q2 2024 to a low of -$11.7 million in Q1 2025.
- Historically, Free Cash Flow has averaged -$5.2 million across 5 years, with a median of -$4.6 million in 2026.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow jumped 70.61% in 2024, then plunged 96.5% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$6.8 million in 2022, then soared by 42.19% to -$3.9 million in 2023, then slumped by 56.17% to -$6.1 million in 2024, then sank by 50.41% to -$9.2 million in 2025, then jumped by 50.36% to -$4.6 million in 2026.
- The last three Free Cash Flow figures came in at -$4.6 million (Q1 2026), -$9.2 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | -4.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.59 Mn |
| Mar 31, 2026 | -4.59 Mn |
| Dec 31, 2025 | -9.25 Mn |
| Dec 31, 2025 | -9.25 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Mar 31, 2025 | -11.71 Mn |
| Mar 31, 2025 | -11.71 Mn |
| Dec 31, 2024 | -6.15 Mn |
| Dec 31, 2024 | -6.15 Mn |
| Sep 30, 2024 | -2.36 Mn |
| Sep 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | -2.29 Mn |
| Jun 30, 2024 | -2.29 Mn |
| Mar 31, 2024 | -5.96 Mn |
| Mar 31, 2024 | -5.96 Mn |
| Dec 31, 2023 | -3.94 Mn |
| Dec 31, 2023 | -3.94 Mn |